Mechanistically, C1q activates the Phosphatidylinositol‐3‐kinase (PI3K)/AKT pathway through interacting with GPR17, a member of the G protein‐coupled receptor family, thereby inducing DNA hypermethylation of tumor cells to promote tumor development. This evidence concerns the gene GPR17 and neoplasm.